“When you’re worth just shy of $4 billion, being cheated out of a couple of million dollars in a suspected wine fraud might seem inconsequential.” In the New York Times, Mosi Secret reports on William Koch’s testimony at Rudy Kurniawan’s trial.
“Given what we’ve seen thus far, it’s amazing they didn’t try to arrange a plea before the trial started.” Tyler Colman reports from day five of the trial.
Eric Asimov offers some holiday wine suggestions for several possible types of gatherings.
“If I could rewind the past and read this book anew, I would treat it like a box of chocolates, to be sampled now and then over a couple of weeks.” Douglas Hillstrom reviews Jon Bonné’s The New California Wine.
Alfonso Cevola ponders the old and the new in California.
“If you can ease off the cork, you’ll preserve those precious bubbles that Dom Pérignon allegedly called ‘drinking the stars.’” In Wine-Searcher, W. Blake Gray looks at “the science of bubbles.”
“‘Everyone wanted to pet him,’ said Ms. Dixon, who trained Elvis to locate the various wine departments in Stew Leonard’s in Norwalk.” In the Wall Street Journal, Lettie Teague writes a wonderful profile of Amy Dixon, a blind sommelier and triathlete.
“The qualities that made her one of the most successful wine importers in the U.S. — decisiveness, determination and extreme efficiency (even if she did grind the gears a bit as she drove away) — were clear in those few frames.” In a different piece, Teague profiles wine importer Martine Saunier.
Robert Joseph wonders if Chateau Lascombes’ decision to sell its wines directly to consumers poses an existential threat to the négociant tradition.
In a separate post, Joseph contends that “Bordeaux may have to rethink the way it handles [the 2013] vintage.”
Speaking of the 2013 vintage, “Robert Parker will not be publishing his report on Bordeaux 2013 until the end of June 2014, two months later than usual.” Gavin Quinney has the details.
“If statistics are any guide, Bond would have died from alcohol- and tobacco-related diseases in his mid-fifties.” An offbeat paper in the British Medical Journal studies James Bond.